Cancer vaccine? Boston researchers optimistic about new treatment
Boston researchers say they may have made a significant breakthrough in the cancer battle by turning malignant cells against themselves.
Recommended Stories
INSIDERA 20-year-old thought she had an insect bite. She was diagnosed with an aggressive form of cancer and died months later.
Jenna Patel, a teaching student, was diagnosed with Ewing's sarcoma while her dad was receiving cancer treatment.
- People
College Student Diagnosed with Cancer After Doctors Dismissed Her: 'People Need to Speak Up for Themselves'
“The doctors were saying nothing's wrong with her, she's fine… I just started to feel like I was crazy,” Jessica Sanders, 21, tells PEOPLE
- TODAY
Woman, 36, details rare cervical cancer diagnosis while pregnant with 1st child
Bethany Hart was diagnosed with small cell cervical cancer, a rare, aggressive type, while pregnant with first child, who died. She hopes to raise awareness.
- Fortune
Vivek Wadhwa: ‘I lost my wife to cancer in 2019–and decided to defeat it for good. Now all of India is joining my quest for world-saving innovation’
Why Silicon Valley entrepreneur Vivek Wadhwa took his grand plan to defeat cancer to India.
- People
The Home Edit's Clea Shearer Starts Ovary Suppression Shots to Start Menopause: 'So Many Feelings'
The celebrity home organizer was declared cancer free in November, seven months after she first revealed she was diagnosed with an aggressive form of breast cancer
- WSOC
Daughter’s diagnosis leads to mother’s breast cancer discovery
Jill Atkins and her daughter, Jaci, have always been close, but their bond is even stronger because of a battle they both faced.
- Reuters
Gilead's breast cancer drug gets U.S. FDA approval for third indication
Gilead Sciences said on Friday the U.S. Food and Drug Administration had greenlighted the use of Trodelvy for a third indication, providing another treatment option for patients with the most common type of breast cancer. The drug was approved for an advanced form of breast cancer with a subtype known as HR-positive/HER2-negative in patients, who had stopped responding to a hormone-based therapy and at least two earlier systemic therapies. Gilead's Trodelvy will likely face competition from AstraZeneca-Daiichi Sankyo's Enhertu, which is approved to treat breast cancer patients with HER2-low type, a subset of HER2-negative breast cancer.
- People
Women Should Consider Removing Fallopian Tubes to Prevent Ovarian Cancer, Experts Say
The new guidance from the Ovarian Cancer Research Alliance comes after the organization found that early screening and detection attempts were not effective in preventing deaths
- Fox News
Ultra-processed food consumption linked to higher risk of death from ovarian, breast cancers: new study
A new study from Imperial's School of Public Health in London found that diets high in ultra-processed foods may elevate the risks of various types of cancer. Here's what to know.
- The Independent
Cancer warning as experts reveal new list of foods that increase risk
Household staples should come with warnings for health risks, say researchers
- The Telegraph
NHS risks being overwhelmed by cancer as cases set to jump by a third, warns leading charity
The NHS risks being overwhelmed by cancer as new cases are expected to jump by a third, a leading charity has warned.
- The Independent
A fake cancer patient was exposed on TikTok. Now, genuine survivors are asking donors not to give up on them
MADDIE RUSSO : Maddie Russo raised more than $37,000 after claiming she was suffering from three forms of aggressive cancer. After her ruse was exposed by experts on TikTok, cancer survivors and charities say they are trying to rebuild trust with the donors they rely on. Bevan Hurley reports.
- Motley Fool
Could Exact Sciences Stock Help You Become a Millionaire?
Exact Sciences (NASDAQ: EXAS) is one of the companies capitalizing on those opportunities. Its Cologuard test screens for colorectal cancer and has helped the company generate significant sales growth along the way. The business is promising and the company also has other tests which help screen for breast cancer and liver cancer.
- Benzinga
Merck's Keytruda Plus Chemo Combo Aces Late-Stage Study In Advanced Endometrial Cancer Patients
Merck & Co Inc's (NYSE: MRK) Phase 3 NRG-GY018 trial evaluating Keytruda (pembrolizumab) combined with standard-of-care chemotherapy (carboplatin and paclitaxel) met its primary endpoint of progression-free survival (PFS). The trial covered patients with stage III-IV or recurrent endometrial carcinoma regardless of mismatch repair status. Related: Merck's Keytruda Phase 3 Trial Meets Primary Endpoint In Gastric Cancer Patients. The treatment regime included Keytruda + Chemo combo, then continued
- American City Business Journals
Here's why 2seventy bio's chief executive thinks 2023 will be a 'special year'
The chief executive of bluebird bio's oncology-focused spinout believes that this year, it will take off as a company in its own right.
- Yahoo Celebrity UK
Sarah Beeny shares photo of her drawing on eyebrows with Biro amid cancer fight
The presenter has been having chemo.
- KMGH - Denver Scripps
Danny New opens up about his journey battling thyroid cancer. What you need to check yourself
You may have noticed Denver7’s Danny New has been off the air for a few weeks and he’s sharing a little about his journey battling thyroid cancer. Danny recently underwent a second surgery at UCHealth to remove around 50 lymph nodes from his neck. He’s doing better now and wanted to share some of his experience and what you need to check because around 42,000 Americans will be diagnosed with thyroid cancer this year, according to the American Cancer Society.
- Benzinga
Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
The FDA has approved Gilead Sciences Inc's (NASDAQ: GILD) Trodelvy (sacituzumab govitecan-hziy) for adult patients with advanced or metastatic breast cancer. The approval covers unresectable locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. The approval is based on statistically significant and clinically meani
- CBS News Videos
Doctor explains new recommendations on preventing ovarian cancer
The Ovarian Cancer Research Alliance issued new recommendations that women at higher risk may want to consider have their fallopian tubes removed to prevent ovarian cancer. Dr. Jamila Perritt, an OB/GYN as well as the president and CEO of Physicians for Reproductive Health, joins CBS News to discuss how to assess the health risks.
- WKBW - Buffalo Scripps
12th annual Shooting For A Cure ready to continue its fight against cancer
In just 12 years, Pembroke High School’s Shooting For a Cure event has raised $227,000 for Roswell Park and cancer research.